Skip to content

NUVL

Nuvalent, Inc.

NASDAQ · USHealthcareBiotechnology
$123.96+0.00%

Price as of Jul 14, 2026

NUVL capital

Nuvalent, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.00x
Net debt / equity
-0.14x
Debt / assets
0.00x
Debt / EBITDA
0.00x
Net debt / EBITDA
0.48x

Liquidity & coverage

Current ratio
16.14x
Quick ratio
16.14x
Cash ratio
15.88x
Interest coverage
-34.11x
EBITDA / interest
-25.99x
Working capital
$1.2B

Cash & dividend

FCF / debt
Cash flow / debt
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.